Skip to main content
PMC home page
World Journal of Surgical Oncology logoLink to World Journal of Surgical Oncology
. 2018 Oct 2;16:196. doi: 10.1186/s12957-018-1499-y

Robotic versus laparoscopic surgery for rectal cancer in male urogenital function preservation, a meta-analysis

Xiaoli Tang 1, Zheng Wang 2, Xiaoqing Wu 2, Meiyuan Yang 1, Daorong Wang 3,✉
PMCID: PMC6169007  PMID: 30285780

Abstract

Background

Urogenital dysfunction after rectal cancer surgery can largely affect patients’ postoperative quality of life. Whether robotic surgery can be a better option when comparing with laparoscopic surgery is still not well-known.

Methods

Comprehensive search in PubMed, Embase, Cochrane Library, and Clinical Trials was conducted to identify relevant studies in March 2018. Studies comparing robotic surgery with laparoscopic surgery were included. Measurement of urogenital function was through the International Prostate Symptom Score and International Index of Erectile Function.

Results

Six studies with 386 patients in robotic group and 421 patients in laparoscopic group were finally included. Pooled analysis indicated that bladder function was better at 12 months in the robotic group after the procedures (mean difference, − 0.30, 95% CI, − 0.52 to − 0.08). No significant difference was found at 3 and 6 months postoperatively (mean difference, − 0.37, 95% CI, − 1.48 to 0.73; mean difference, − 1.21, 95% CI, − 2.69 to 0.28). Sexual function was better at 3 months in the robotic group after surgery (mean difference, − 3.28, 95% CI, − 6.08 to − 0.49) and not significantly different at 6 and 12 months. (mean difference, 3.78, 95% CI, − 7.37 to 14.93; mean difference, − 2.82, 95% CI, − 8.43 to 2.80).

Conclusion

Robotic surgery may offer faster recovery in urogenital function compared to laparoscopic surgery for rectal cancer.

Background

Rectal cancer is one of the most common malignant neoplasm worldwide [1, 2]. Great improvement in management of rectal cancer has been made over the past few decades, such as recommendation for early screening in high-risk population and use of adjuvant and neoadjuvant chemotherapy [3–5]. However, even with lots of newly invented treatments, surgery is still the only curative treatment for rectal cancer to achieve radical resection so the patient can gain oncological safety. In the past two decades, minimal invasive surgery like laparoscopy has been accepted worldwide. Existed randomized control trials have proved the certain superiority of laparoscopy over conventional open surgery with equal oncological safety [6–8]. Robotic surgery was first used in colorectal disease in 2001 [9], since then, it has gained great popularity around the world as it overcomes some technical limitations compared to laparoscopic surgery. Although the main goals of rectal surgery are accomplishing adequate distal and circumferential margins, postoperative function outcomes like sexual and urological functions greatly influence postoperative psychological well-being and account for a large part of patients’ quality of life [10–13]. Previous studies have illustrated urogenital impairment after rectal surgery with approximately 5% of patients suffer permanent bladder dysfunction or impotence problem [14, 15]. When compared to laparoscopy, whether robotic surgery can be a better option regarding recovery of sexual and urological function is still under great debate. The present study aimed at answering this question with current available evidence by conducting a meta-analysis.

Methods

A comprehensive search was conducted in March 2018 within PubMed, Embase, Cochrane Library, and Clinical Trials. The searching terms were “Colorectal Neoplasms” [Mesh] + “Laparoscopy” [Mesh] + “Robotic Surgical Procedures” [Mesh] + “sexual dysfunction” or “sexual impairment” + “urological dysfunction” or “urological impairment.” Clinical studies from January 2001 till the search day which compared robotic surgery with laparoscopic surgery with sexual or urological outcomes as primary or secondary endpoints were identified for further screening, as well as studies containing a subgroup of participants whose urogenital functions were recorded. We included studies both designed as randomized control trials or observational studies. Non-human papers, comment, letter, correspondence, review, expert opinions, and case reports were excluded. Studies with irrelevant topics and studies with no records regarding sexual and urological function were excluded as well. The screening process was shown in Fig. 1. Two researchers independently screened the articles without any consult. If any disagreement occurred, the article was brought into discussion to decide whether it will be included. Data extraction from each enrolled study mainly included author, year, study design, information feasible for quality evaluation, patients baseline date, tumor-related information, operative procedure, and functional outcomes both preoperatively and postoperatively. The Review Manager software (version 5.3) from Cochrane was used to analyze the extracted data under the instruction of Cochrane handbook.

Fig. 1.

Fig. 1

Open in a new tab

Study screening flow

Results

After screening, six studies [16–21] were included in this meta-analysis. Three hundred and eighty-six patients in total underwent robotic surgery and 421 patients underwent laparoscopic surgery. Among six studies, four of them were retrospectively designed [16–19] and the other two were randomized control trials (RCT) [20, 21]. We used the Newcastle–Ottawa scale to evaluate the quality of observational studies (shown in Table 1) and the risks of bias system from Cochrane to assess the quality of RCTs. Basic characteristics of the studies were summarized in Table 2.

Table 1.

NOS scale for observational studies

Study Selection Comparability Outcome assessment Score
1 2 3 4 5, 6 7 8 9
D’ Annibale 2013 * * * * *, * * * * 9
Panteleimonitis 2016 * * * * *, 0 * * * 8
Park 2014 * * * * *, * * * * 9
Kim 2012 * * * * *, * * * * 9
Open in a new tab

Explanation

1: Adequate definition of the cases, study-enrolled cases with independent validation. (yes, *; no or not reported, 0)

2: Representative of the cases, consecutive or obviously representative cases. (yes, *; no or not reported, 0)

3: Selection of controls, community controls. (yes, *; no or not reported, 0)

4: Clear definition of the controls, no previous history of the same procedure. (yes, *; no or not reported, 0)

5: Comparability of cases and controls on the basis of the design or analysis, the patients baseline characteristics were similar between different groups. (yes, *; no or not reported, 0)

6: Comparability of cases and controls for other factors, the same type of procedure, the same surgical team to perform the procedure. (yes, *; no or not reported, 0)

7: Ascertainment of exposure, complete surgical records. (yes, *; no or not reported, 0)

8: Same method of ascertainment for cases and controls. (yes, *; no or not reported, 0)

9: Adequacy of follow up of cohorts (yes, *; no or not reported, 0)

Table 2.

Characteristics of the included studies

Author Year Country Study design No. of robotic procedures No. of laparoscopic procedures Methods of function assessment
Wang 2016 China RCT 71 66 IPSS, IEFF
Jayne 2017 UK RCT 175 176 IPSS, IEFF
Panteleimonitis 2016 UK Retrospective 48 78 IPSS,IEFF
Park 2014 Korea Retrospective 32 32 IPSS, IEFF
Kim 2012 Korea Retrospective 30 39 IPSS, IEFF
D‘Annibale 2013 Italy Retrospective 30 30 IPSS, IEFF
Open in a new tab

Abbreviation: UK, United Kingdom; RCT, randomized controlled trial; IPSS, International Prostate Symptom Score; IEFF, International Index of Erectile Function

Urological function

All studies used the International Prostate Symptom Score (IPSS) to evaluate the patients urological function mainly concerning seven aspects as bladder emptying, frequency, intermittency, nocturia, urgency, straining, and weak stream. Each aspect of the scale ranges from 0 to 6 points with higher scores indicate worse function. All studies recorded IPSS preoperatively as baseline status. To minimize heterogeneity among different religions regarding sexual and urological functions, we used the change in the scores from baseline to analyze the difference. Two studies reported IPSSs 3 months after surgery. The pooled estimate indicated that there was no significant difference between the two groups. (mean difference, − 1.21, 95% CI, − 2.69 to 28, p = 0.11). No heterogeneity was found among studies. Four studies recorded IPSSs 6 months after the surgery, and the result showed no significant difference between laparoscopy and robotic procedure (mean difference, − 0.37 95% CI − 1.47 to 0.73, p = 0.51). Moderate heterogeneity was found among studies with I2 = 60%, so the random effect model was used and publication bias was detected by conducting the funnel plot (Fig. 5). Four studies reported IPSSs of 12 months after the surgery, and the result favored robotic surgery (mean difference, − 0.30 95% CI, − 0.52 to − 0.08 p = 0.007). Almost no heterogeneity was found among studies with I2 = 1%. Forest plots and funnel plots were shown in Figs. 2, 3, 4, 5, 6, and 7.

Fig. 5.

Fig. 5

Open in a new tab

Funnel plot for IPSS at 3 months

Fig. 2.

Fig. 2

Open in a new tab

IPSS change from baseline at 3 months postoperatively

Fig. 3.

Fig. 3

Open in a new tab

IPSS change from baseline at 6 months postoperatively

Fig. 4.

Fig. 4

Open in a new tab

IPSS change from baseline at 12 months postoperatively

Fig. 6.

Fig. 6

Open in a new tab

Funnel plot for IPSS at 6 months

Fig. 7.

Fig. 7

Open in a new tab

Funnel plot for IPSS at 12 months

Sexual function

All studies used the International Index of Erectile Function (IIEF) score to assess patients’ sexual function. The IIEF is a well-recognized self-report questionnaire scale which contains five factors as erectile function, orgasmic function, libido, intercourse satisfaction, and overall satisfaction [22]. The higher scores also indicated better sexual function. To minimize the impact of heterogeneity among different studies, we used the change from baseline date of each study to analyze. Only two studies reported IIEF at 3 months after surgery, and the result favored robotic surgery (mean difference − 3.28, 95% CI − 6.08 to − 0.49, p = 0.02). Four studies recorded IIEF scores at 6 months after surgery, and the result showed no significant difference between the two groups (mean difference, 3.78 95% CI − 7.37 to 14.93, p = 0.51). Great heterogeneity was found among studies with I2 = 99%. Two studies reported IIEF scores at 12 months after surgery, and the result showed no significant difference among the two groups (mean difference, − 2.82, 95% CI, − 8.43 to 2.80). Moderate heterogeneity was found with I2 = 42%. The forest plots and funnel plots of IIEF were shown in Figs. 8, 9, 10, 11, 12 and 13.

Fig. 8.

Fig. 8

Open in a new tab

IIEF score change from baseline at 3 months postoperatively

Fig. 9.

Fig. 9

Open in a new tab

IIEF score change from baseline at 6 months postoperatively

Fig. 10.

Fig. 10

Open in a new tab

IIEF score change from baseline at 12 months postoperatively

Fig. 11.

Fig. 11

Open in a new tab

Funnel Plot for IIEF at 3 months

Fig. 12.

Fig. 12

Open in a new tab

Funnel Plot for IIEF at 6 months

Fig. 13.

Fig. 13

Open in a new tab

Funnel Plot for IIEF at 12 months

Discussion

Robotic surgery for colorectal cancer has been widely accepted over the past decade. High-quality evidence such as RCTs and meta-analysis has suggested that robotic surgery can achieve oncological safety compared to laparoscopy with lower conversion rate and faster recovery [23, 24]. However, it is still not well explored whether the advantages of robotic surgery can translate into better urogenital function after the procedure. Few previously published meta-analyses have tried to answer this question with available evidence. For the specific topic of urogenital function outcomes, Malene Broholm et al. conducted a meta-analysis with 10 studies enrolled [25]. They suggested that IPSS was better at 3 months and 12 months after surgery in robotic surgery group. As for IIEF score, they found better results in robotic group at both 3 and 6 months after surgery. However, they found that the feasible data from these 10 studies were scarce; thus the results should be interpreted cautiously. Another meta-analysis conducted by Lee et al. found that robotic patients had a better IPSS at 3 months after surgery, but this superiority did not present at 6 months and 12 months [23]. As for sexual function, researchers found that patients in robotic surgery had better IIEF scores at both 3 and 6 months postoperatively. However, they also claimed limitations in their study, like limited data and vague information about follow-ups. They were also concerned about the impact of equipment learning curve on postoperative outcomes because all the procedures were not performed by the same surgical team. Panteleimonitis et al. did a critical analysis of currently available evidence of urogenital function following robotic surgery for rectal cancer [26]. They searched the literature for studies of robotic surgery without conducting a meta-analysis due to great heterogeneity. They concluded that there seemed to be a trend towards better urogenital function following robotic surgery when comparing with laparoscopic surgery. However, they found that many identified studies were not well-designed, so that it was not feasible to form a high-quality evidence based on the situation.

The present study found that IPSSs at 12 months were better after robotic surgery. No significant difference was found between laparoscopic and robotic procedures at 3 and 6 months. However, previous studies have indicated that the minimum perceptible differences detected by IPSS should be more than 3 points [27]. Our result showed that the pooled difference between the two groups was only 0.3. Therefore, this significant difference should be interpreted cautiously. Further evidence with larger samples and more comprehensive investigation of urological function is needed to form a more solid conclusion. As for sexual function recovery, the study found that at 3 months after the procedure, patients that underwent robotic surgery scored better at IIEF. This difference was not found at 6 months and 12 months.

Normal bladder and sexual function were regulated by intact supply of parasympathetic and sympathetic nerve. These regulation nerves usually lie among the pelvic side-walls which make them susceptible to be injured during rectal resection [28]. Although the appearance of urogenital dysfunction is polyfactorial, iatrogenic damage during surgery is thought to be the main cause [29–31]. In addition, urogenital dysfunction after the procedures largely depends on perioperative damage to the autonomic nerve and the site of anastomosis [11, 32]. In conventional laparoscopic surgery, the leading surgeon had to dissect the rectum in a narrow pelvic space with stiff equipment. In these cases, the autonomic nerve lying among the pelvic walls are easily damaged especially when the tumor is bulky [33]. Robotic surgery is supposed to conquer these technical limitations due to its flexible-wristed tremor-free instruments which mimic the surgeon’s hands. In addition, based on a stable platform, the camera, which can provide a high-definition 3D image, is easier to control. These advantages should theoretically benefit patients with better nerve preservation, thus better postoperative functional outcomes.

The present meta-analysis has certain limitations. The most important one is that many detail information concerning the height of anastomosis and type of surgery, whether the patients were sexually active before the procedures, are not mentioned in the original studies. We figured that it is one of the reasons for great heterogeneity among studies. In addition, lack of detailed information can also bring great confounding factors which made the result less reliable. Another limitation is scarce data. Although we included newly published studies, the estimable data for each result is still not abundant enough to establish a solid conclusion. However, we did find it crucial to provide necessary education and counseling about possible urogenital dysfunction after rectal surgery to help patients facilitate realistic expectation and psychological preparation, especially in preoperative sexually active patients [34, 35].

Conclusion

Our study formed a primary result that rectal cancer patients underwent robotic surgery may recover faster in urological functions 12 months postoperatively. As for sexual function recovery, patients gained better sexual function at 3 months postoperatively in robotic group while no significant difference was found between robotic surgery and laparoscopic surgery at 6 and 12 months. Future well-designed, larger enrolled participant studies are needed to further address this question for rectal cancer patients.

Acknowledgments

Funding information

The authors received funding from Jiangsu Provincial Science and Technology Department, grant number BE2015664.

Availability of data and materials

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Abbreviations

CI

Confidence interval

IIEF

International Index of Erectile Function

IPSS

International Prostate Symptom Score

RCT

Randomized control trials

Authors’ contributions

The paper was written by XT and MY. Study search and screening were done by ZW and XW. Date analysis was done by XT. The whole process was instructed by DW. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Xiaoli Tang, Zheng Wang, Xiaoqing Wu, Meiyuan Yang, and Daorong Wang declared that they have no conflict of interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Xiaoli Tang, Email: tangxiaoli@csu.edu.cn.

Zheng Wang, Email: wangzhengzhengwang@126.com.

Xiaoqing Wu, Email: 1905710396@qq.com.

Meiyuan Yang, Email: yangmeiyuan@csu.edu.cn.

Daorong Wang, Phone: 0514-82985500, Email: wdaorong666@sina.com.

Reference

  • 1.Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi: 10.1002/ijc.29210. [DOI] [PubMed] [Google Scholar]
  • 2.Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–117. doi: 10.3322/caac.21220. [DOI] [PubMed] [Google Scholar]
  • 3.van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer. 2014;50(1):1.e–e34. doi: 10.1016/j.ejca.2013.06.048. [DOI] [PubMed] [Google Scholar]
  • 4.Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–1482. doi: 10.1016/S0140-6736(86)91510-2. [DOI] [PubMed] [Google Scholar]
  • 5.Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg. 1982;69(10):613–616. doi: 10.1002/bjs.1800691019. [DOI] [PubMed] [Google Scholar]
  • 6.Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100(1):75–82. doi: 10.1002/bjs.8945. [DOI] [PubMed] [Google Scholar]
  • 7.Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97(11):1638–1645. doi: 10.1002/bjs.7160. [DOI] [PubMed] [Google Scholar]
  • 8.Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008;(2):Cd003432. [DOI] [PMC free article] [PubMed]
  • 9.Weber PA, Merola S, Wasielewski A, Ballantyne GH. Telerobotic-assisted laparoscopic right and sigmoid colectomies for benign disease. Dis Colon Rectum. 2002;45(12):1689–1694. doi: 10.1007/s10350-004-7261-2. [DOI] [PubMed] [Google Scholar]
  • 10.Traa MJ, De Vries J, Roukema JA, Den Oudsten BL. Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review. Ann Oncol. 2012;23(1):19–27. doi: 10.1093/annonc/mdr133. [DOI] [PubMed] [Google Scholar]
  • 11.Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg. 2003;238(2):203–213. doi: 10.1097/01.sla.0000080823.38569.b0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hassan I, Cima RR. Quality of life after rectal resection and multimodality therapy. J Surg Oncol. 2007;96(8):684–692. doi: 10.1002/jso.20916. [DOI] [PubMed] [Google Scholar]
  • 13.Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg. 2005;242(2):212–223. doi: 10.1097/01.sla.0000171299.43954.ce. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gogenur I, Wittendorff HE, Colstrup H, Rosenberg J, Fischer A. Complications after treatment of colorectal cancer, with special focus on stomas, urological conditions and sexual dysfunction. Ugeskr Laeger. 2005;167(45):4272–4275. [PubMed] [Google Scholar]
  • 15.Donovan KA, Thompson LM, Hoffe SE. Sexual function in colorectal cancer survivors. Cancer Control. 2010;17(1):44–51. doi: 10.1177/107327481001700106. [DOI] [PubMed] [Google Scholar]
  • 16.Kim JY, Kim NK, Lee KY, Hur H, Min BS, Kim JH. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol. 2012;19(8):2485–2493. doi: 10.1245/s10434-012-2262-1. [DOI] [PubMed] [Google Scholar]
  • 17.Panteleimonitis S, Ahmed J, Ramachandra M, Farooq M, Harper M, Parvaiz A. Urogenital function in robotic vs laparoscopic rectal cancer surgery: a comparative study. Int J Color Dis. 2017;32(2):241–248. doi: 10.1007/s00384-016-2682-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.D’Annibale A, Pernazza G, Monsellato I, Pende V, Lucandri G, Mazzocchi P, et al. Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc. 2013;27(6):1887–1895. doi: 10.1007/s00464-012-2731-4. [DOI] [PubMed] [Google Scholar]
  • 19.Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, Yun SH. Urinary and erectile function in men after total mesorectal excision by laparoscopic or robot-assisted methods for the treatment of rectal cancer: a case-matched comparison. World J Surg. 2014;38(7):1834–1842. doi: 10.1007/s00268-013-2419-5. [DOI] [PubMed] [Google Scholar]
  • 20.Wang Gang, Wang Zhiming, Jiang Zhiwei, Liu Jiang, Zhao Jian, Li Jieshou. Male urinary and sexual function after robotic pelvic autonomic nerve-preserving surgery for rectal cancer. The International Journal of Medical Robotics and Computer Assisted Surgery. 2016;13(1):e1725. doi: 10.1002/rcs.1725. [DOI] [PubMed] [Google Scholar]
  • 21.Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA. 2017;318(16):1569–1580. doi: 10.1001/jama.2017.7219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–830. doi: 10.1016/S0090-4295(97)00238-0. [DOI] [PubMed] [Google Scholar]
  • 23.Lee SH, Lim S, Kim JH, Lee KY. Robotic versus conventional laparoscopic surgery for rectal cancer: systematic review and meta-analysis. Ann Surg Treat Res. 2015;89(4):190–201. doi: 10.4174/astr.2015.89.4.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Zhang X, Wei Z, Bie M, Peng X, Chen C. Robot-assisted versus laparoscopic-assisted surgery for colorectal cancer: a meta-analysis. Surg Endosc. 2016;30(12):5601–5614. doi: 10.1007/s00464-016-4892-z. [DOI] [PubMed] [Google Scholar]
  • 25.Broholm M, Pommergaard HC, Gogenur I. Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis. Color Dis. 2015;17(5):375–381. doi: 10.1111/codi.12872. [DOI] [PubMed] [Google Scholar]
  • 26.Panteleimonitis S, Ahmed J, Harper M, Parvaiz A. Critical analysis of the literature investigating urogenital function preservation following robotic rectal cancer surgery. World J Gastrointest Surg. 2016;8(11):744–754. doi: 10.4240/wjgs.v8.i11.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Barry Michael J. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology. 2001;58(6):25–32. doi: 10.1016/S0090-4295(01)01300-0. [DOI] [PubMed] [Google Scholar]
  • 28.Leung Alex L.H., Chan Wai-Hong, Cheung Hester Y.S., Lui Gilbert K.L., Fung James T.K., Li Michael K.W. Initial experience on the urogenital outcomes after robotic rectal cancer surgery. Surgical Practice. 2013;17(1):13–17. doi: 10.1111/j.1744-1633.2012.00626.x. [DOI] [Google Scholar]
  • 29.Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol. 2011;8(1):51–57. doi: 10.1038/nrurol.2010.206. [DOI] [PubMed] [Google Scholar]
  • 30.Havenga K, Enker WE. Autonomic nerve preserving total mesorectal excision. Surg Clin North Am. 2002;82(5):1009–1018. doi: 10.1016/S0039-6109(02)00044-0. [DOI] [PubMed] [Google Scholar]
  • 31.Masui H, Ike H, Yamaguchi S, Oki S, Shimada H. Male sexual function after autonomic nerve-preserving operation for rectal cancer. Dis Colon Rectum. 1996;39(10):1140–1145. doi: 10.1007/BF02081416. [DOI] [PubMed] [Google Scholar]
  • 32.Moriya Y. Function preservation in rectal cancer surgery. Int J Clin Oncol. 2006;11(5):339–343. doi: 10.1007/s10147-006-0608-z. [DOI] [PubMed] [Google Scholar]
  • 33.Quah HM, Jayne DG, Eu KW, Seow-Choen F. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg. 2002;89(12):1551–1556. doi: 10.1046/j.1365-2168.2002.02275.x. [DOI] [PubMed] [Google Scholar]
  • 34.Ness RM, Holmes A, Klein R, Greene J, Dittus R. Outcome states of colorectal cancer: identification and description using patient focus groups. Am J Gastroenterol. 1998;93(9):1491–1497. doi: 10.1111/j.1572-0241.1998.00469.x. [DOI] [PubMed] [Google Scholar]
  • 35.Holzer B, Gyasi A, Schiessel R, Rosen HR. Patients' expectations of colorectal surgery for cancer. Color Dis. 2006;8(3):186–191. doi: 10.1111/j.1463-1318.2005.00901.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Articles from World Journal of Surgical Oncology are provided here courtesy of BMC

RESOURCES